pharmaceutical investing Antibe Therapeutics Announces Successful Completion of Part One of Phase 2B Dose-Ranging, Efficacy Study for ATB-346
pharmaceutical investing Antibe Therapeutics Receives Approval to Initiate Part Two of Phase 2B Dose-Ranging, Efficacy Study for ATB-346
Walker Lane Resources Ltd. Receives TSX Approval for the Acquisition of Three Mineral Properties in the Walker Lane Gold Trend in Nevada from Silver Range Resources Ltd. and Auburn Gold
